LEPU MED.T.B. SP.GDR O.N.
Lepu Medical Technology (Beijing) Co., Ltd. develops, manufactures, and distributes medical devices and equipment worldwide. The company offers peripheral interventional products, including Supercross PTA balloon dilatation catheters, Angiocide peripheral cutting balloons, and PeakSheath disposable artery sheath; and cardiovascular products, such as coronary stents and balloons, catheters, guide … Read more
Market Cap & Net Worth: LEPU MED.T.B. SP.GDR O.N. (07Z0)
LEPU MED.T.B. SP.GDR O.N. (F:07Z0) has a market capitalization of $131.28K (€127.89K) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #3406 globally and #312 in its home market, demonstrating a -1.53% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying LEPU MED.T.B. SP.GDR O.N.'s stock price €12.90 by its total outstanding shares 9914 (9.91K).
LEPU MED.T.B. SP.GDR O.N. Market Cap History: 2022 to 2026
LEPU MED.T.B. SP.GDR O.N.'s market capitalization history from 2022 to 2026. Data shows change from $125.63K to $131.28K (-1.29% CAGR).
LEPU MED.T.B. SP.GDR O.N. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how LEPU MED.T.B. SP.GDR O.N.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 07Z0 by Market Capitalization
Companies near LEPU MED.T.B. SP.GDR O.N. in the global market cap rankings as of March 18, 2026.
Key companies related to LEPU MED.T.B. SP.GDR O.N. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #79 globally with a market cap of $190.05 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #153 globally with a market cap of $121.18 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #169 globally with a market cap of $112.92 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #191 globally with a market cap of $103.18 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #79 | Abbott Laboratories | NYSE:ABT | $190.05 Billion | $109.95 |
| #153 | Stryker Corporation | NYSE:SYK | $121.18 Billion | $349.56 |
| #169 | Medtronic PLC | NYSE:MDT | $112.92 Billion | $88.24 |
| #191 | Boston Scientific Corp | NYSE:BSX | $103.18 Billion | $69.79 |
LEPU MED.T.B. SP.GDR O.N. Historical Marketcap From 2022 to 2026
Between 2022 and today, LEPU MED.T.B. SP.GDR O.N.'s market cap moved from $125.63K to $ 131.28K, with a yearly change of -1.29%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €131.28K | -2.27% |
| 2025 | €134.33K | -9.59% |
| 2024 | €148.58K | +3.55% |
| 2023 | €143.49K | +14.21% |
| 2022 | €125.63K | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of LEPU MED.T.B. SP.GDR O.N. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $131.28K USD |
| MoneyControl | $131.28K USD |
| MarketWatch | $131.28K USD |
| marketcap.company | $131.28K USD |
| Reuters | $131.28K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.